Cortical Neurons In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Cortical neurons in Alzheimer's disease (AD) undergo significant degeneration that underlies the cognitive decline characteristic of the disease. The cortex, particularly the hippocampus and association cortices, shows extensive neuronal loss, synaptic dysfunction, and pathological protein accumulation.
The hippocampus is among the first and most affected regions:
- CA1 pyramidal neurons: Severely vulnerable
- CA3 pyramidal neurons: Moderate vulnerability
- Dentate gyrus granule cells: Relatively preserved
- CA2 pyramidal neurons: Relatively resistant
- Layer II neurons: Early tau pathology (Brodmann area 28)
- Preclinical changes: Memory deficits correlate
- Gateway dysfunction: Disconnection from hippocampus
- Posterior cingulate: Early hypometabolism
- Superior parietal: Visuospatial dysfunction
- Temporal-parietal junction: Attention deficits
- Prefrontal cortex: Executive dysfunction
Cortical layer 5 pyramidal neurons show:
- Tau pathology: Neurofibrillary tangles
- Amyloid effects: Aβ toxicity
- Synaptic loss: Dendritic spine reduction
- Metabolic impairment: Reduced glucose metabolism
Various interneuron types are affected:
- Parvalbumin (PV) neurons: Reduced in AD
- Somatostatin (SST) neurons: Vulnerable
- VIP neurons: Relatively preserved
- Chandelier cells: GABAergic dysfunction
Tau in cortical neurons:
- Hyperphosphorylation: AT8, AT100, PHF-tau
- Oligomer formation: Toxic soluble species
- Tangle formation: Neurofibrillary tangles
- Spread: Transsynaptic propagation
Aβ effects on cortical neurons:
- Synaptic dysfunction: Impaired LTP
- Calcium dysregulation: Homeostatic disruption
- Oxidative stress: ROS accumulation
- Mitochondrial dysfunction: Energy failure
- Spine loss: Particularly mushroom spines
- Presynaptic changes: Reduced neurotransmitter release
- Network disruption: Cortical hyperexcitability
- Functional connectivity: Default mode network impairment
Hippocampal-cortical loops:
- Entorhinal-hippocampal: Early dysfunction
- Papez circuit: Memory circuit disruption
- Cortical integration: Impaired consolidation
- Salience network: Changed in early AD
- Default mode network: Reduced deactivation
- Executive network: Dorsolateral prefrontal
¶ Cognitive Domains
Neuronal loss correlates with:
| Region |
Cognitive Domain |
Symptoms |
| Hippocampus |
Episodic memory |
Forgetting recent events |
| Entorhinal |
Navigation |
Getting lost |
| Parietal |
Visuospatial |
Spatial disorientation |
| Prefrontal |
Executive |
Planning difficulties |
- Preclinical: Subtle changes, no symptoms
- MCI: Detectable deficits
- Mild AD: Functional impairment
- Moderate to severe: Global cognitive decline
- Cholinesterase inhibitors: Protect synaptic function
- Memantine: NMDA receptor modulation
- Aβ-targeted: Reduce amyloid burden
- Tau-targeted: Prevent tangle formation
- Neuroprotective agents: Target vulnerable neurons
- Synaptic restoration: Spine regeneration
- Network modulation: Restore connectivity
- Cell replacement: Stem cell therapies
The study of Cortical Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Morrison JH, Hof PR. (1997). Life and death of neurons in the aging brain. Science. PMID:9141579.
- Selkoe DJ. (2002). Alzheimer's disease is a synaptic failure. Science. PMID:12417715.
- Arendt T. (2009). Synaptic degeneration in Alzheimer's disease. Acta Neuropathologica. PMID:19381738.
- Palop JJ, Mucke L. (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease. Nature. PMID:21068840.
- Busche MA, Hyman BT. (2020). Synergy between amyloid-beta and tau in Alzheimer's disease. Nature Neuroscience. PMID:32747785.